Oprah Winfrey Reflects on Missed Opportunities with GLP-1 Medication

Oprah Winfrey, at 71, has expressed her regret over not having incorporated GLP-1 medications into her health management regimen sooner, primarily due to the emotional toll it took on her over the years.

In a discussion with CBS Sunday Morning, Oprah shared how redefining obesity as an illness allowed her to detach her self-worth from her weight.

Reflecting on her past struggles, Winfrey mentioned, 'I've spent numerous nights believing it was my personal burden to bear, wondering why I couldn't overcome it.'

She revealed that the constant preoccupation with food disappeared soon after she first tried a GLP-1 medication.

Oprah emphasized that such medications are merely tools that can assist in overcoming obstacles related to weight.

Despite her enduring love for food, she now approaches it with a sense of detachment, no longer feeling any compulsive pull towards it.

Acknowledging the medication as a continuing necessity for managing her health, she lamented not having known about it sooner.

Since she became aware of the treatment in 2013, she can't help but dwell on the missed opportunities and the emotional burden she carried in those years.

Yet, Oprah speaks of a renewed appreciation for her health and body consciousness, particularly at her current age.

Drawing a comparison with her younger self, she stated that while she once appreciated the strength needed to run a marathon at 40, the depth of gratitude she feels now is unparalleled.

Oprah conveyed that being fit at 71 requires significantly more effort and dedication than at 40, giving her a sense of profound achievement and perspective.

Her battles with weight over the years have taught her to value contemporary medical solutions.

Expressing her gratitude, she said she feels privileged to have access to these medications that can alter lives.

Oprah first publicized her use of a GLP-1 drug in December 2023, without specifying which one.

By December 2025, she revealed she had ceased the medication for a year to see if she could manage without it, resulting in a weight gain of 20 pounds.

Comparing it to her high blood pressure treatment, she realized the necessity of maintaining the GLP-1 medication for continued health.

Semaglutide, a GLP-1 drug, works by regulating appetite signals, thereby helping people feel satisfied with less food consumption. However, potential side effects include nausea and digestive issues. Studies also indicate that stopping the medication can lead to regaining the lost weight.